摘要
缺血性脑卒中是心房颤动(简称房颤)患者最常见的并发症,具有很高的致残率和致死率。而合理的抗栓治疗是降低脑卒中的有效方法,同时存在出血的风险,尤其是脑出血。所以用口服抗栓药物时,往往要评估脑卒中及出血的风险。现就如何权衡房颤抗栓治疗的疗效和安全性及常见脑卒中与脑出血的共同影响因素进行分析评价。
Ischemic stroke is the most common complication in patients with atrial fibrillation,with high morbidity and mortality.Reasonable antithrombotic treatment is an effective way to reduce stroke,however there is the risk of bleeding,especially cerebral hemorrhage.Therefore,the use of oral antithrombotic drugs decision must be based on assessment of stroke and bleeding risks,.Here is to make an analysis and evaluation of the stroke and cerebral hemorrhage common factors,and how to balance the efficacy and safety of antithrombotic treatment in atrial fibrillation.
出处
《医学综述》
2012年第12期1867-1870,共4页
Medical Recapitulate
基金
新疆维吾尔自治区自然科学基金(2010211A44)
关键词
心房颤动
抗栓治疗
脑卒中
脑出血
Atrial fibrillation
Antithrombotic treatment
Stroke
Cerebral hemorrhage
